££......Osmetech ......Smell the Success.....££

Vialogy of which OIP hold a stake, following initial research seems a very interesting company, and certainly should be of interest to the osmetech management.

VMAxS™ service, ViaLogy’s first product, is a highly focused, web-based application for re-processing raw data files from microarray scanners, such as Affymetrix GeneChip® scanners. VMAxS™ service provides higher quality gene expression data for input to user’s statistics and bioinformatics platforms. Gene expression data from microarrays is used by major pharmaceutical, biotech and agricultural companies, and institutional, government and core laboratories for research and development in molecular and cellular biology, genomics, genetics and pharmaceutical sciences. VMAxS™ service is available on-demand and pay-per-use or by custom projects with ViaLogy.

I think an e-mail is required to Osmetech to find out if this technology is likely to be implemented to the E-sensor.

I would be very interested trout or any one else for that matter if you have an opinion on OIP, as moving forward OMH and OIP may offer similar growth opportunities, and who's to say not working together.